Axikin Pharmaceuticals Receives $6,000,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b1da46b0-5c31-4da1-8d6b-a1cf1ba6b467
Date
3/27/2014
Company Name
Axikin Pharmaceuticals
Mailing Address
10835 Road To The Cure San Diego, CA 92121 USA
Company Description
The Axikin discovery biology and portfolio of small molecules focuses on novel GPCR and kinase targets central to the inflammatory process, the antagonism of which is predicted to ameliorate allergic respiratory disorders such as rhinitis and asthma, in addition to significantly impacting the inflammation observed in COPD.
Website
http://www.axikin.com
Transaction Type
Venture Equity
Transaction Amount
$6,000,000
Transaction Round
Undisclosed
Proceeds Purposes
This filing includes amounts receivable by the Company upon the exercise of Warrants to purchase shares of the Company’s Common Stock, assuming no cashless exercise. Such Warrants have not yet been issued. Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor